Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
about
Challenges in Prevention and Care Delivery for Women with Cervical Cancer in Sub-Saharan AfricaAssessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic ApproachEpidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell CarcinomaSystematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent ImmunizationsPopulation-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisCosting of National STI Program Implementation for the Global STI Control Strategy for the Health Sector, 2016-2021.Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.Anal dysplasia in HIV-infected women: a commentary on the field.Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in SwazilandCosts of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countriesThe economic burden of human papillomavirus-related precancers and cancers in Sweden.Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian WomenKnowledge about virus biology is crucial for usHealth care access dimensions and cervical cancer screening in South Africa: analysis of the world health surveyCost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in ChinaHighest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden.The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach.Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China.Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancerThe next steps in cervical screening.Prophylactic HPV vaccination: past, present, and future.The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique.Worldwide burden of cancer attributable to HPV by site, country and HPV type.Awareness and prevalence of cervical cancer screening among women in Nepal.Trends in the Incidence of Oropharyngeal Cancers in the United States.Human papillomavirus related oropharyngeal cancer.Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States.HPV vaccination: The most pragmatic cervical cancer primary prevention strategy.Awareness and Knowledge Levels of Turkish College Students about Human Papilloma Virus Infection and Vaccine Acceptance.Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study.Relaxation and guided imagery do not reduce stress, pain and unpleasantness for 11- to 12-year-old girls during vaccinations.Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.Universal proposal strategies of anti-HPV vaccination for adolescents: comparative analysis between school-based and clinic immunization programs.
P2860
Q26742113-22887230-F2DE-4FA7-8B30-651EE51D0180Q26779543-ECEAB2B0-E4FF-40F5-9E77-73E93C6B6F2BQ26782499-C45A7D90-DFAD-4C80-9988-2D01116B89F1Q28078812-38BBE485-E282-493F-A2BE-A196B9B0FCD5Q28084924-19DB50AA-794F-4C3A-A837-70BB9BF7458CQ29247953-C7F6E1F9-7FCC-4ABC-ADCC-B963D9662F6FQ30245295-A8F27F02-E620-4607-9399-9E4B7456967EQ30251408-600AC149-77C4-48E6-A61F-FF3BD4A1AF0FQ30251868-15335E7D-F18C-43D0-A0F6-5BD2F1EBA23BQ30252055-94347359-02DC-4E9F-B80D-97FFC714E8D8Q33692293-287A6115-234D-4069-BA15-7E2FF20BFC03Q33713018-E41F10F9-EF09-49DD-AB04-820CEE7C726FQ33812737-7D30F77C-1AA7-4B77-B144-2EC1CB7BF669Q33834660-BC996547-DD66-4E14-8042-1E749F580056Q33859491-058967FE-64DB-4521-9F40-60662ACE3BFFQ35028286-143CEF3E-E64A-4460-9B1D-D370029C0A95Q35496442-3A4F191E-9705-41F7-87C3-D10A7922E5BAQ35784964-712B9D98-BF00-46D6-BC43-62A326752838Q35937679-BAA169D5-1C70-4D84-B0A6-1B8C2BA4B544Q35956489-7509A7D8-4ADA-4BC1-9023-9404B6A66916Q36109733-E8DEBA68-AB8B-4810-B920-62F5F50FBE3AQ36183172-6AB240DC-B728-4492-BCDB-39EDED5AE1BBQ36237280-13BC80CC-2483-4A65-8669-59F9BC0BAB53Q36914109-899B30E3-D5AE-45FB-917E-8CD723AF0DB8Q37135163-65E460B9-59E2-46F6-BEBE-BF0265479379Q38380092-4DF5CE32-5F23-403F-9ABC-4AE15256B273Q38597567-03B1F4E7-D69F-4B67-935A-861B946551F8Q38687001-7C7142D3-2EE2-4F24-B597-F68F198D0217Q38747551-B8469D5A-5350-4BC1-AFE5-D4E6CF409211Q38859779-D99858AF-901B-40FD-9B87-B3DB7C636960Q39748568-65ADD3CE-C4A8-4521-B75C-1F10F4B6F610Q39955058-A6B74758-98D0-4F5C-8D87-6C317FD16C8AQ40152615-0684A1FB-9F13-4084-9DF7-8292E74864C7Q40464632-DD1D151C-EB83-4B5E-8827-F14126D975F0Q40470651-D13F72E1-37EF-440F-BAB4-736340357250Q40531853-DD2F560B-D80A-46D0-9205-EA4C33BEAAA7Q40688577-875A7712-8CC5-4A7F-85C4-241D2AEBFE85Q42155601-DAC993E9-44B7-43BF-8BE9-83EEDC2F15C0Q42706838-6EC174AE-F407-40C8-A664-BB49C9385C1AQ44732567-EC98E414-0075-4F02-8A04-ACC7DE7E7CBC
P2860
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@en
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@nl
type
label
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@en
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@nl
prefLabel
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@en
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@nl
P2093
P1476
Cost-effectiveness of female h ...... ries: a PRIME modelling study.
@en
P2093
Allison Portnoy
Marc Brisson
Raymond Hutubessy
P304
P356
10.1016/S2214-109X(14)70237-2
P50
P577
2014-06-09T00:00:00Z